Leczenie przedoperacyjne chorych na raka piersi i jego wpływ na postępowanie operacyjne oraz radioterapeutyczne. Część 1.

Q4 Medicine Nowotwory Pub Date : 2021-02-05 DOI:10.5603/NJO.2021.0004
Zbigniew I. Nowecki, A. Jagiełło-Gruszfeld, K. Pogoda, A. Niwińska, W. Olszewski, Paweł Winter, R. Matkowski, W. Wysocki
{"title":"Leczenie przedoperacyjne chorych na raka piersi i jego wpływ na postępowanie operacyjne oraz radioterapeutyczne. Część 1.","authors":"Zbigniew I. Nowecki, A. Jagiełło-Gruszfeld, K. Pogoda, A. Niwińska, W. Olszewski, Paweł Winter, R. Matkowski, W. Wysocki","doi":"10.5603/NJO.2021.0004","DOIUrl":null,"url":null,"abstract":"Neoadjuvant therapy (NAT) is increasingly applied in patients with initially inoperable breast cancers and, frequently, in those with tumours that are initially operable, too. In most cases, the response to the applied NAT affects the scope of surgical treatment and radiotherapy, and in some situations also the complementary systemic postoperative treatment. The available studies indicate importance of response to NAT within the breast and regional lymph nodes. Assessment of response to treatment allows personalization of treatment and in some cases a change of therapy, which improves long-term outcomes. This article summarizes the current rules of conduct in patients with early breast cancer qualified for neoadjuvant thera­py, paying attention to the practical aspects and possibilities of national health insurance-covered therapies in Poland. It discusses in detail the applied regimens of systemic therapy, surgical techniques, eligibility rules and complementary radiotherapy. Systems for assessing response to neoadjuvant treatment are also presented.","PeriodicalId":39938,"journal":{"name":"Nowotwory","volume":"139 1","pages":"17-25"},"PeriodicalIF":0.0000,"publicationDate":"2021-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nowotwory","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5603/NJO.2021.0004","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 1

Abstract

Neoadjuvant therapy (NAT) is increasingly applied in patients with initially inoperable breast cancers and, frequently, in those with tumours that are initially operable, too. In most cases, the response to the applied NAT affects the scope of surgical treatment and radiotherapy, and in some situations also the complementary systemic postoperative treatment. The available studies indicate importance of response to NAT within the breast and regional lymph nodes. Assessment of response to treatment allows personalization of treatment and in some cases a change of therapy, which improves long-term outcomes. This article summarizes the current rules of conduct in patients with early breast cancer qualified for neoadjuvant thera­py, paying attention to the practical aspects and possibilities of national health insurance-covered therapies in Poland. It discusses in detail the applied regimens of systemic therapy, surgical techniques, eligibility rules and complementary radiotherapy. Systems for assessing response to neoadjuvant treatment are also presented.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
新辅助治疗(NAT)越来越多地应用于最初不能手术的乳腺癌患者,也经常应用于那些最初也可以手术的肿瘤患者。在大多数情况下,对应用NAT的反应会影响手术治疗和放疗的范围,在某些情况下还会影响辅助的全身术后治疗。现有的研究表明,在乳房和区域淋巴结对NAT的反应的重要性。对治疗反应的评估可以使治疗个性化,在某些情况下可以改变治疗方法,从而改善长期结果。本文总结了目前符合新辅助治疗条件的早期乳腺癌患者的行为规则,重点关注波兰国家健康保险覆盖治疗的实际方面和可能性。它详细讨论了全身治疗的应用方案,手术技术,资格规则和补充放疗。评估对新辅助治疗反应的系统也被提出。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Nowotwory
Nowotwory Medicine-Oncology
CiteScore
0.90
自引率
0.00%
发文量
44
期刊介绍: NOWOTWORY Journal of Oncology publishes papers which cover all aspects of oncology but concentrates on clinical studies, both research orientated and treatment orientated, rather than on laboratory studies. Contributions are also welcomed from the fields of epidemiology, tumor pathology, radiobiology and radiation physics.
期刊最新文献
Once upon a time in oncology – will we definitely win a war against cancer? Critical review of the progresses in cancer therapies Wnt pathways in focus – mapping current clinical trials across cancer spectrum The influence of fluid therapy on short and long – term outcome in patients undergoing liver resection for malignant indications Pharmacological prevention methods in patients with cardiovascular disease with breast cancer – when, how, and for whom? Retrospective analysis of the treatment of BRCA1 and BRCA2 mutation carriers – the experience of a single-center tertiary institution
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1